Stanniocalcin 1 and 1,25-dihydroxyvitamin D3 cooperatively regulate bone mineralization by osteoblasts
Experimental & Molecular Medicine · 2024
DOI: 10.1038/s12276-024-01302-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental & Molecular Medicine, 2024. Verfasst von Jung Ha Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Chonnam National University Medical School, Gwangju, 61469, Republic of Korea. Hauptthemen laut MEDLINE: Calcification, Physiologic, Calcitriol, Cell Differentiation, Glycoproteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Stanniocalcin 1 (STC1) is a calcium- and phosphate-regulating hormone that is expressed in all tissues, including bone tissues, and is involved in calcium and phosphate homeostasis. Previously, STC1 expression was found to be increased by 1,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ] administration in renal proximal tubular cells. In this study, we investigated whether STC1 directly regulates osteoblast differentiation or reciprocally controls the effects of 1,25(OH) 2 D 3 on osteoblasts to contribute to bone homeostasis. We found that STC1 inhibited osteoblast differentiation in vitro and bone morphogenetic protein 2 (BMP2)-induced ectopic bone formation in vivo. Moreover, 1,25(OH) 2 D 3 increased STC1 expression through direct binding to the Stc1 promoter of the vitamin D receptor (VDR). STC1 activated the 1,25(OH) 2 D 3 –VDR signaling pathway through the upregulation of VDR expression mediated by the inhibition of Akt phosphorylation in osteoblasts. STC1 further increased the effects of 1,25(OH) 2 D 3 on receptor activator of nuclear factor-κB ligand (RANKL) secretion and inhibited osteoblast differentiation by exhibiting a positive correlation with 1,25(OH) 2 D 3 . The long-bone phenotype of transgenic mice overexpressing STC1 specifically in osteoblasts was not significantly different from that of wild-type mice. However, compared with that in the wild-type mice, 1,25(OH) 2 D 3 administration significantly decreased bone mass in the STC1 transgenic mice. Collectively, these results suggest that STC1 negatively regulates osteoblast differentiation and bone formation; however, the inhibitory effect of STC1 on osteoblasts is transient and can be reversed under normal conditions. Nevertheless, the synergistic effect of STC1 and 1,25(OH) 2 D 3 through 1,25(OH) 2 D 3 administration may reduce bone mass by inhibiting osteoblast differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Chonnam National University Medical School, Gwangju, 61469, Republic of Korea.
- Hard-Tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju, 61186, Republic of Korea.
- Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju, 61186, Republic of Korea.
- Department of Pharmacology, Chonnam National University Medical School, Gwangju, 61469, Republic of Korea. nacksung@jnu.ac.kr.
- Hard-Tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju, 61186, Republic of Korea. nacksung@jnu.ac.kr.
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Kim, J. H., Kim, K., Kim, I., Seong, S., Koh, J. T., & Kim, N. (2024). Stanniocalcin 1 and 1,25-dihydroxyvitamin D3 cooperatively regulate bone mineralization by osteoblasts. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-024-01302-2
Vancouver
Kim JH, Kim K, Kim I, Seong S, Koh JT, Kim N. Stanniocalcin 1 and 1,25-dihydroxyvitamin D3 cooperatively regulate bone mineralization by osteoblasts. Experimental & Molecular Medicine. 2024. doi:10.1038/s12276-024-01302-2
BibTeX
@article{Kim2024,
author = {Kim, Jung Ha and Kim, Kabsun and Kim, Inyoung and Seong, Semun and Koh, Jeong-Tae and Kim, Nacksung},
title = {Stanniocalcin 1 and 1,25-dihydroxyvitamin D3 cooperatively regulate bone mineralization by osteoblasts},
journal = {Experimental & Molecular Medicine},
year = {2024},
doi = {10.1038/s12276-024-01302-2}
}
EUVIMED